Physician profile
Eric W Shultz
NPI 1366628075
$552.46
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $191 · 2021: $51.70 · 2022: $42.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $188.79 | 2019-2020 | |
| Grt US Holding, INC. | $40.41 | 2021 | |
| Crossroads Extremity Systems, LLC | $39.16 | 2020 | |
| Horizon Therapeutics Plc | $34.38 | 2019-2020 | |
| Wright Medical Technology, INC. | $33.03 | 2019-2020 | |
| Tenex Health INC. | $31.83 | 2020 | |
| Merck Sharp & Dohme LLC | $25.40 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.04 | 2019 | |
| Sebela Pharmaceuticals INC. | $19.16 | 2019 | |
| Kci USA, INC. | $17.92 | 2020 | |
| Treace Medical Concepts, INC. | $17.60 | 2022 | |
| Medtronic Vascular, INC. | $15.26 | 2019 | |
| Edwards Lifesciences Corporation | $14.73 | 2020 | |
| Zimvie INC. | $13.66 | 2022 | |
| Dynasplint Systems INC. | $11.30 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $11.29 | 2021 | |
| Aroa Biosurgery Incorporated | $10.96 | 2022 | |
| Next Science LLC | $7.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.